Managed Healthcare Executive3h
FDA Approves NDA for Gilead's new HIV Prevention Shot
Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving ...
Monthly Prescribing Reference7h
Twice-Yearly Lenacapavir Gets Priority Review For HIV PrEP
The Food and Drug Administration (FDA) has accepted under Priority Review the New Drug Application (NDA) for lenacapavir, a long-acting HIV-1 capsid inhibitor, for the prevention of HIV as ...
GlobalData on MSN9h
Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP use
The US Food and Drug Administration (FDA) has accepted Gilead’s new drug application (NDA) for lenacapavir and set a prescription drug user fee act (PDUFA) target action date of ...
unaids9h
How the shift in US funding is threatening both the lives of people affected by HIV and the community groups supporting them
By paralyzing frontline response efforts led by community groups, the US decision to freeze funding is weakening health systems across the Global South. The freeze not only jeopardizes precious gains ...
Healio11h
FDA sets date for decision on twice-yearly shots to prevent HIV
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
Utah Public Radio12h
A breakthrough HIV drug was developed using Utah biochemistry research
An HIV drug was named “2024 Breakthrough of the Year” by Science Magazine. Biochemistry research from the University of Utah ...
Scientists develop new natural killer cell strategy to target HIV
Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
Gilead Gets FDA Priority Review of Twice-Yearly Shot to Prevent HIV
Gilead Sciences has won Food and Drug Administration priority review for its proposed lenacapavir twice-yearly shot to prevent HIV. Gilead on Tuesday said an FDA green light would make lenacapavir the ...
HIV protein switch may help virus squeeze into host cell nucleus
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...
Q&A: Researchers discuss stigma, unequal access and aging population, all challenges to HIV care and prevention
Despite breakthroughs in HIV treatment and prevention worldwide, critical challenges such as stigma, unequal access and ...
Canada6d
HIV and AIDS: Symptoms and treatment
With treatment, people living with HIV can have long and healthy lives. However, if left untreated, it can cause a weakened immune system or acquired immune deficiency syndrome (AIDS). Some people may ...